Fungal Infections

Diasorin C. auris test gets FDA de novo authorization

By LabPulse.com staff writers

Diasorin has received de novo authorization from the U.S. Food and Drug Administration (FDA) for its test kit for Candida auris, a multidrug-resistant fungal pathogen common in healthcare settings.

July 16, 2024

BioMérieux researchers describe rise of multidrug-resistant Candida auris infections

By Elissa Wolfson

A retrospective analysis of blood cultures detecting Candida auris found an upsurge of this pathogenic yeast between 2021 and 2023.

June 19, 2023

Indiana University researchers analyze the performance of tests detecting Candida auris

By Elissa Wolfson

Researchers seeking better antifungal susceptibility tests measured the accuracy of four available tests for use with Candida auris, a pathogenic yeast.

June 19, 2023

Contagious fungal infections increase dramatically

By Elissa Wolfson

Candidiasis infections caused by Candida auris, a highly contagious fungus, rose dramatically between 2019 and 2021, reflecting increased transmission.

March 21, 2023

Diagnostics for fungal pathogens lack standardization

By Leah Sherwood

Clinicians from the U.S. and Europe discussed molecular diagnostic approaches to fungal infections and the research work done so far to standardize assays during a series of talks at Infectious Disease Week (IDWeek) meeting, held virtually from September 29 to October 3.

October 26, 2021

Test identifies any infection from any sample in hours

By LabPulse.com staff writers

Scientists from the University of California, San Francisco developed the test, which requires no special handling or processing for each specific bodily fluid and uses next-generation DNA sequencing technology. It accounts for all DNA in a single sample. The test uses a new analytical software application to compare DNA sequences in the sample to genomic databases that cover all bacterial, viral, parasitic, or fungal infections from any species.

November 10, 2020

Thoracic guideline advises newer tests for fungal infections

By LabPulse.com staff writers

Based on a systematic review of the scientific literature, the guideline covers lab tests for diagnosing invasive pulmonary aspergillosis, invasive candidiasis, histoplasmosis, blastomycosis, and coccidioidomycosis, among other infections. Options reviewed include the following:

August 29, 2019

Labs gear up to diagnose novel fungal infection

By Bruce Carlson

In the past few years, more than 600 cases of an emerging fungal infection called Candida auris have been identified in 12 U.S. states, according to the CDC.

April 14, 2019

Page 1 of 1